The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells

被引:41
作者
Punzel, M
Moore, KA
Lemischka, IR
Verfaillie, CM
机构
[1] Univ Minnesota, Dept Med, Div Hematol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Stem Cell Biol Program, Minneapolis, MN 55455 USA
[3] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
关键词
LTC-IC-assessment; stromal feeder; M2-10B4; AFT024;
D O I
10.1038/sj.leu.2401234
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The goal of this study was to evaluate if differences in culture conditions used in long-term culture assays affect enumeration of LTC-IC in freshly sorted or ex vivo expanded CD34(+)/HLA-DRdim/CD2(-)/CD7(-) (34(+)/Lin(-)) cells. The variables examined included different stromal feeders (murine bone marrow fibroblast cell line, M2-10B4 and murine fetal liver cell line, AFT024) and presence or absence of cytokines (MIP-1 alpha + IL-3). The absolute LTC-IC frequency in 34(+)/Lin(-) cells measured in limiting dilution assays (LDA) on AFT024 (4.45 +/- 0.69%) was significantly higher than in M2-10B4 (1.45 +/- 0.20%) LDA. Addition of MIP-1 alpha and IL-3 to AFT024 LDA increased the measured LTC-IC frequency to 6.8 +/- 0.9%. We also determined the fraction of LTC-IC that persisted after 34(+)/Lin(-) cells were cultured for 5 weeks by replating progeny in the three LDA readout systems. The measured LTC-IC maintenance was significantly lower when M2-10B4 LDA (13.1 +/- 3.5%, P < 0.05) were used compared with AFT024 LDA (36.6 +/- 5.5%) or AFT024 LDA supplemented with MIP-1 alpha and IL-3 (29.1 +/- 6.3%). Thus, the number of LTC-IC measured in freshly sorted 34(+) cells depends on the stromal feeder used in LDA assays. Furthermore, and most important, assessment of LTC-IC expansion or maintenance may vary significantly depending on the type of stromal feeder used to enumerate LTC-IC.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 44 条
[31]   PURIFICATION AND CHARACTERIZATION OF MOUSE HEMATOPOIETIC STEM-CELLS [J].
SPANGRUDE, GJ ;
HEIMFELD, S ;
WEISSMAN, IL .
SCIENCE, 1988, 241 (4861) :58-62
[32]   FUNCTIONAL-CHARACTERIZATION OF INDIVIDUAL HUMAN HEMATOPOIETIC STEM-CELLS CULTURED AT LIMITING DILUTION ON SUPPORTIVE MARROW STROMAL LAYERS [J].
SUTHERLAND, HJ ;
LANSDORP, PM ;
HENKELMAN, DH ;
EAVES, AC ;
EAVES, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3584-3588
[33]  
SUTHERLAND HJ, 1993, LEUKEMIA, V7, pS122
[34]   DIFFERENTIAL REGULATION OF PRIMITIVE HUMAN HEMATOPOIETIC-CELLS IN LONG-TERM CULTURES MAINTAINED ON GENETICALLY ENGINEERED MURINE STROMAL CELLS [J].
SUTHERLAND, HJ ;
EAVES, CJ ;
LANSDORP, PM ;
THACKER, JD ;
HOGGE, DE .
BLOOD, 1991, 78 (03) :666-672
[35]   QUANTITATIVE ASSAY FOR TOTIPOTENT RECONSTITUTING HEMATOPOIETIC STEM-CELLS BY A COMPETITIVE REPOPULATION STRATEGY [J].
SZILVASSY, SJ ;
HUMPHRIES, RK ;
LANSDORP, PM ;
EAVES, AC ;
EAVES, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8736-8740
[36]  
TASWELL C, 1981, J IMMUNOL, V126, P1614
[37]   PHENOTYPIC ANALYSIS OF MURINE LONG-TERM HEMATOPOIETIC RECONSTITUTING CELLS QUANTITATED COMPETITIVELY IN-VIVO AND COMPARISON WITH MORE ADVANCED COLONY-FORMING PROGENY [J].
TREVISAN, M ;
ISCOVE, NN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :93-103
[38]   PURIFIED PRIMITIVE HUMAN HEMATOPOIETIC PROGENITOR CELLS WITH LONG-TERM INVITRO REPOPULATING CAPACITY ADHERE SELECTIVELY TO IRRADIATED BONE-MARROW STROMA [J].
VERFAILLIE, C ;
BLAKOLMER, K ;
MCGLAVE, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :509-520
[39]  
VERFAILLIE C, 1991, BLOOD, V77, P263
[40]   MACROPHAGE INFLAMMATORY PROTEIN 1-ALPHA, INTERLEUKIN-3 AND DIFFUSIBLE MARROW STROMAL FACTORS MAINTAIN HUMAN HEMATOPOIETIC STEM-CELLS FOR AT LEAST 8 WEEKS IN-VITRO [J].
VERFAILLIE, CM ;
CATANZARRO, PM ;
LI, WN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :643-649